News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Proneuron Biotechnologies, Inc. (US Branch) Welcomes Dr. Marca L. Sipski To The Company's ProCord Study Steering Committee Guiding The Phase II Study Of ProCord For Complete Spinal Cord Injury


10/19/2005 5:10:19 PM

Proneuron Biotechnologies announced today that Dr. Marca Sipski is the newest member of the Company's Procord Study Steering Committee, tasked to oversee the Phase II study of ProCord, an experimental procedure for complete spinal cord injury now in progress in the U.S and Israel.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES